Cancer Family
Malignant Soft Tissue Neoplasm
CI-CAN-00000251Explore in graph →
341 active trials9 approved drugs37 evidence items
- NCIt
- C4867
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000251Explore in graph →
Rankings
13 current ranking rows (latest year per scope). Each row lists the scope, the formula version, the value and the exact inputs that produced it.
| Metric | Scope | Rank / eligible | Δ | Value | Percentile | Confidence | Formula | Generated | Inputs |
|---|---|---|---|---|---|---|---|---|---|
| Curated clinical evidence items | World · both sexes · all ages · latest · all malignant entities | #97 / 492 | = | 37 count | 80.4 | Medium confidence | ci-civic-evidence-v1 | Sep 29, 2026 | showformula: COUNT(civic_evidence_items) WHERE status = ACCEPTED AND cancer_id IN descendants(cancer)
inputs hash 00ec4259c26ee135c931f5a6 Trace lineage (admin) |
| Genes with curated or cohort evidence | World · both sexes · all ages · latest · all malignant entities | #208 / 521 | = | 15 count | 60.2 | Medium confidence | ci-genes-v1 | Sep 29, 2026 | showformula: COUNT(DISTINCT gene) FROM (civic accepted evidence ∪ gdc frequency ≥ 0.05 AND cases_affected ≥ 20)
inputs hash dc02edfbbd5b601934401df4 Trace lineage (admin) |
| Public genomic cohorts | World · both sexes · all ages · latest · all malignant entities | #210 / 296 | = | 2 count | 29.2 | Medium confidence | ci-cohorts-v1 | Sep 29, 2026 | showformula: COUNT(genomic_cohorts) WHERE cancer_id IN descendants(cancer)
inputs hash 401b2e31f9813fbae9c90ab7 Trace lineage (admin) |
| Publications, last 12 months | World · both sexes · all ages · latest · all malignant entities | #592 / 2,294 | = | 31 count | 74.2 | Medium confidence | ci-pubs-12m-v1 | Sep 29, 2026 | showformula: literature_counts.count WHERE window_key = 12m
inputs hash 6636ad9f834652e029647409 Trace lineage (admin) |
| Publications, last 5 years | World · both sexes · all ages · latest · all malignant entities | #607 / 2,873 | = | 151 count | 78.9 | Medium confidence | ci-pubs-5y-v1 | Sep 29, 2026 | showformula: literature_counts.count WHERE window_key = 5y (query stored per row)
inputs hash 531d42217f151c0dd79899a6 Trace lineage (admin) |
| Publication growth | World · both sexes · all ages · latest · all malignant entities | #135 / 286 | = | 1.15 ratio | 53 | Medium confidence | ci-pub-growth-v1 | Sep 29, 2026 | showformula: publications_12m / (publications_5y_prior / 5)
inputs hash 3385afecab0ace04e61b6db0 Trace lineage (admin) |
| Trial registration growth (year over year) | World · both sexes · all ages · latest · all malignant entities | #173 / 186 | = | -0.19 ratio | 7 | Medium confidence | ci-trial-growth-v1 | Sep 29, 2026 | showformula: (new_trials_12m − new_trials_prior_12m) / new_trials_prior_12m (first_posted_date windows; interventional; descendants)
|
| Active clinical trials | World · both sexes · all ages · latest · all malignant entities | #113 / 1,654 | = | 341 count | 93.2 | Medium confidence | ci-active-trials-v1 | Sep 29, 2026 | showformula: COUNT(DISTINCT trial) FROM trial_conditions JOIN clinical_trials WHERE cancer_id IN descendants(cancer) AND study_type = INTERVENTIONAL AND overall_status IN (RECRUITING, NOT_YET_RECRUITING, ENROLLING_BY_INVITATION, ACTIVE_NOT_RECRUITING)
inputs hash f2f5ed2084d93bba6dcb810e Trace lineage (admin) |
| Active Phase III trials | World · both sexes · all ages · latest · all malignant entities | #131 / 810 | = | 23 count | 83.9 | Medium confidence | ci-phase3-trials-v1 | Sep 29, 2026 | showformula: COUNT(DISTINCT trial) … active statuses AND PHASE3 = ANY(phases)
inputs hash 56fba75197c8c0044b9e345f Trace lineage (admin) |
| Recruiting clinical trials | World · both sexes · all ages · latest · all malignant entities | #111 / 1,277 | = | 190 count | 91.4 | Medium confidence | ci-recruiting-trials-v1 | Sep 29, 2026 | showformula: COUNT(DISTINCT trial) … overall_status = RECRUITING AND study_type = INTERVENTIONAL
inputs hash 4352f89d0670b61272a585b3 Trace lineage (admin) |
| Recruiting Phase III trials | World · both sexes · all ages · latest · all malignant entities | #123 / 585 | = | 14 count | 79.1 | High confidence | ci-phase3-recruiting-v1 | Sep 29, 2026 | showformula: COUNT(DISTINCT trial) … overall_status = RECRUITING AND PHASE3 = ANY(phases) AND study_type = INTERVENTIONAL
inputs hash ada23aaf0a7d803bc6e67424 Trace lineage (admin) |
| Sponsor concentration (HHI) | World · both sexes · all ages · latest · all malignant entities | #502 / 615 | = | 0.015 index (0–1) | 18.4 | High confidence | ci-sponsor-hhi-v1 | Sep 29, 2026 | showformula: Σ (active_trials_by_lead_sponsor / active_trials)² over the cancer and its descendants
|
| Trial termination share | World · both sexes · all ages · latest · all malignant entities | #278 / 454 | = | 0.33 ratio | 38.9 | High confidence | ci-trial-termination-v1 | Sep 29, 2026 | showformula: (terminated + withdrawn) / (completed + terminated + withdrawn) WHERE first_posted_date ≥ 2010-01-01 AND study_type = INTERVENTIONAL
|
Computed Ranks are competition ranks (ties share a rank). Percentile = share of eligible entities ranked at or below this one in the ranking direction.
"Deadliest" is ambiguous: annual deaths, age-standardized mortality rate, mortality-to-incidence ratio and 5-year survival rank cancers differently. CancerIndex publishes each as a separate metric.
inputs hash f271e5ec1a95b0a8843d9337
inputs hash d0a365cf448b4492e5842c02
inputs hash b91f4c1d0fc49c7e7afbbdb1
Unmet need · computed
No research-gap components for this entity